Works matching IS 0893133X AND DT 2005 AND VI 30 AND IP 9

Results: 23

The RGSZ2 Protein Exists in a Complex with μ-Opioid Receptors and Regulates the Desensitizing Capacity of Gz Proteins.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1632, doi. 10.1038/sj.npp.1300726

By:

Garzón, Javier;
Rodriguez-Muñoz, Maria;
López-Fando, Almudena;
Sánchez-Blázquez, Pilar

Publication type:

Article

Novelty Seeking and Stereotypic Activation of Behavior in Mice with Disruption of the Dat I Gene.

Published in:

2005

By:

Pogorelov, Vladimir M.;
Rodriguez, Ramona M.;
Insco, Megan L.;
Caron, Marc G.;
Wetsel, William C.

Publication type:

Correction Notice

Dr. Julius Axelrod, 19122004.

Published in:

2005

By:

Snyder, Solomon H.

Publication type:

Obituary

Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McNS6S2 and [11C]DASB.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1741, doi. 10.1038/sj.npp.1300736

By:

McCann, Una D.;
Szabo, Zsolt;
Seckin, Esen;
Rosenblatt, Peter;
Mathews, William B.;
Ravert, Hayden T.;
Dannals, Robert F.;
Ricaurte, George A.

Publication type:

Article

Association Study of a Monoamine Oxiclase A Gene Promoter Polymorphism with Major Depressive Disorder and Antidepressant Response.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1719, doi. 10.1038/sj.npp.1300785

By:

W-Y Yu, Younger;
Shih-Jen Tsai;
Chen-Jee Hong;
Tai-Jui Chen;
Ming-Chao Chen;
Chih-Wei Yang

Publication type:

Article

Reply: Plasma Leptin and Antipsychotic-Induced Body Weight Gain.

Published in:

2005

By:

Haupt, Dan;
Newcomer, John

Publication type:

Letter

Plasma Leptin and Antipsychotic-Induced Body Weight Gain.

Published in:

2005

By:

Monteleone, Palmiero;
Fabrazzo, Michele;
Maj, Mario

Publication type:

Letter

Ernest B Sigg, 1924-2004.

Published in:

2005

By:

Horst, W Dale;
Moyer, John A.;
Scholosser, Walter;
Sulser, Fridolin

Publication type:

Obituary

Rats Maintained Chronically on Buprenorphine Show Reduced Heroin and Cocaine Seeking in Tests of Extinction and Drug-Induced Reinstatement.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1681, doi. 10.1038/sj.npp.1300712

By:

Sorge, Robert E.;
Rajabi, Heshmat;
Stewart, Jane

Publication type:

Article

Effects of Low- and High-Nicotine Cigarette Smoking on Mood States and the HPA Axis in Men.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1751, doi. 10.1038/sj.npp.1300753

By:

Mendelson, Jack H.;
Sholar, Michelle B.;
Goletiani, Nathalie;
Siegel, Arthur J.;
Mello, Nancy K.

Publication type:

Article

The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1649, doi. 10.1038/sj.npp.1300710

By:

Dorph-Petersen, Karl-Anton;
Pierri, Joseph N.;
Perel, James M.;
Zhuoxin Sun;
Sampson, Allan R.;
Lewis, David A.

Publication type:

Article

Glutamatergic Dysfunction in OCD.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1735, doi. 10.1038/sj.npp.1300733

By:

Chakrabarty, Kaushik;
Bhattacharyya, Sagnik;
Christopher, Rita;
Khanna, Sumant

Publication type:

Article

The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1724, doi. 10.1038/sj.npp.1300728

By:

Del-Ben, Cristina M.;
Deakin, JF William;
Mckie, Shane;
Delvau, Nucola A.;
Williams, Steve R.;
Elliott, Rebecca;
Dolan, Mairead;
Anderson, Ian M.

Publication type:

Article

Cluster B Personality Disorders are Associated with Allelic Variation of Monoamine Oxidase A Activity.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1711, doi. 10.1038/sj.npp.1300737

By:

Jacob, Christian P.;
Müller, Johannes;
Schmidt, Michael;
Hohenberger, Katrin;
Gutknecht, Lise;
Reif, Andreas;
Schmidtke, Armin;
Móssner, Rainald;
Lesch, Klaus Peter

Publication type:

Article

Association of Multiple DRD2 Polymorphisms with Anorexia Nervosa.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1703, doi. 10.1038/sj.npp.1300719

By:

Bergen, Andrew W.;
Yeager, Meredith;
Welch, Robert A.;
Haque, Kashif;
Ganjei, J Kelly;
van den Bree, Marianne BM.;
Mazzanti, Chiara;
Nardi, Irma;
Fichter, Manfred M.;
Halmi, Katherine A.;
Kaplan, Allan S.;
Strober, Michael;
Treasure, Janet;
Woodside, D Blake;
Bulik, Cynthia M.;
Bacanu, Silviusalin;
Devlin, Bernie;
Berrettini, Wade H.;
Goldman, David;
Kaye, Walter H.

Publication type:

Article

Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1693, doi. 10.1038/sj.npp.1300711

By:

Gresch, Paul J.;
Smith, Randy L.;
Barrett, Robert J.;
Sanders-Bush, Elaine

Publication type:

Article

Lack of CBI Cannabinoid Receptor Impairs Cocaine Self-Administration.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1670, doi. 10.1038/sj.npp.1300707

By:

Soria, Guadalupe;
Mendizábal, Victoria;
Touriño, Clara;
Robledo, Patricia;
Ledent, Catherine;
Parmentier, Marc;
Maldonado, Rafael;
Valverde, Olga

Publication type:

Article

Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior Inhibition by CRFI- and Benzodiazepine-Receptor Antagonists and a 5-HT Ia-Receptor Agonist.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1662, doi. 10.1038/sj.npp.1300706

By:

Breese, George R.;
Overstreet, David H.;
Knapp, Darin J.;
Navarro, Montserrat

Publication type:

Article

Effect of Increased Serotonin Levels on [18F]MPPF Binding in Rat Brain: Fenfluramine vs the Combination of Citalopram and Ketanserin.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1624, doi. 10.1038/sj.npp.1300721

By:

Udo De Haes, Joanna I.;
Cremers, Thomas IFH.;
Bosker, Fokko-J;
Folkert6Postema;
Tiemersma-Wegman, Theodora D.;
den Boer, Johan A.

Publication type:

Article

Chronic Low-Dose Corticosterone Supplementation Enhances Acquired Epileptogenesis in the Rat Amygdala Kindling Model of TLE.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1610, doi. 10.1038/sj.npp.1300709

By:

Taher, Taufik R.;
Salzberg, Michael;
Morris, Margaret J.;
Rees, Sandra;
O'Brien, Terence J.

Publication type:

Article

ERβ-Selective Estrogen Receptor Modulators Produce Antianxiety Behavior when Administered Systemically to Ovariectomized Rats.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1598, doi. 10.1038/sj.npp.1300713

By:

Waif, Alicia A.;
Frye, Cheryl A.

Publication type:

Article

Gestational Dexamethasone Treatment Elicits Sex-Dependent Alterations in Locomotor Activity, Reward-Based Memory and Hippocampal Cholinergic Function in Adolescent and Adult Rats.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1617, doi. 10.1038/sj.npp.1300716

By:

Kreider, Marisa L.;
Levin, Edward D.;
Seidler, Frederic J.;
Slotkin, Theodore A.

Publication type:

Article

Effects of Altered Amygdalar Neuropeptide Y Expression on Anxiety-Related Behaviors.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 9, p. 1589, doi. 10.1038/sj.npp.1300705

By:

Primeaux, Stefany D.;
Wilson, Steven P.;
Cusick, Michael C.;
York, David A.;
Wilson, Marlene A.

Publication type:

Article

Works matching IS 0893133X AND DT 2005 AND VI 30 AND IP 9

The RGSZ2 Protein Exists in a Complex with μ-Opioid Receptors and Regulates the Desensitizing Capacity of Gz Proteins.

Novelty Seeking and Stereotypic Activation of Behavior in Mice with Disruption of the Dat I Gene.

Dr. Julius Axelrod, 19122004.

Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [<sup>11</sup>C]McNS6S2 and [<sup>11</sup>C]DASB.

Association Study of a Monoamine Oxiclase A Gene Promoter Polymorphism with Major Depressive Disorder and Antidepressant Response.

Reply: Plasma Leptin and Antipsychotic-Induced Body Weight Gain.

Plasma Leptin and Antipsychotic-Induced Body Weight Gain.

Ernest B Sigg, 1924-2004.

Rats Maintained Chronically on Buprenorphine Show Reduced Heroin and Cocaine Seeking in Tests of Extinction and Drug-Induced Reinstatement.

Effects of Low- and High-Nicotine Cigarette Smoking on Mood States and the HPA Axis in Men.

The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys.

Glutamatergic Dysfunction in OCD.

The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study.

Cluster B Personality Disorders are Associated with Allelic Variation of Monoamine Oxidase A Activity.

Association of Multiple DRD2 Polymorphisms with Anorexia Nervosa.

Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex.

Lack of CBI Cannabinoid Receptor Impairs Cocaine Self-Administration.

Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior Inhibition by CRF<sub>I</sub>- and Benzodiazepine-Receptor Antagonists and a 5-HT <sub>Ia</sub>-Receptor Agonist.

Effect of Increased Serotonin Levels on [<sup>18</sup>F]MPPF Binding in Rat Brain: Fenfluramine vs the Combination of Citalopram and Ketanserin.

Chronic Low-Dose Corticosterone Supplementation Enhances Acquired Epileptogenesis in the Rat Amygdala Kindling Model of TLE.

ERβ-Selective Estrogen Receptor Modulators Produce Antianxiety Behavior when Administered Systemically to Ovariectomized Rats.

Gestational Dexamethasone Treatment Elicits Sex-Dependent Alterations in Locomotor Activity, Reward-Based Memory and Hippocampal Cholinergic Function in Adolescent and Adult Rats.

Effects of Altered Amygdalar Neuropeptide Y Expression on Anxiety-Related Behaviors.